Science Corporation is a clinical-stage medical technology company

With dozens of patients in six countries enrolled in our ongoing clinical studies, we are committed to translating innovations from bench to bedside for the benefit of everyone.

We work to restore quality of life to those with debilitating conditions for which there are no treatment options, creating devices aimed at restoring vision, cognition, and mobility to patients who have lost it. To support progress across our industry, we provide state-of-the-art components and vertically integrated infrastructure for others to build on via Science Foundry.

Headquartered in Alameda, California, we are a global company with secondary offices in Research Triangle Park, North Carolina and Paris, France.

A scientist works behind the partially closed sash of a biosafety cabinet.
A people operations specialist walking a dog outside the Science Corporation office. The dog's name is Edith.

Our Values

  • Patients First

    We believe that all patients should have agency over their lives and that patient needs must be prioritized, especially the right to privacy.

    We believe that patient desires must be respected and prioritized in treatment. We want to make sure all patients have fair and equal access to care and innovation.

  • Responsible for the Common Good

    We are committed to setting high ethical standards for our industry. We recognize that our work is new and must be explained and understood.

    We will work with governments, civil society, and other leading companies (including competitors) to define and set rules and regulations for our industry. We are scientists and engineers deeply committed to working for the common good, responsibly and safely, with care and compassion for all living things and for our planet.

  • Modern Pioneers

    We are modern pioneers set on pursuing new frontiers of medicine, science, and technology to advance human well-being.

    We believe that neurotechnology is on the cusp of important breakthroughs that will significantly improve human life. We are determined to help lead that effort, and to ensure patients have the best and most complete access possible to innovative technologies that address their condition.

  • Following Science Where it Leads

    We hire the smartest people we can find and rely on their good judgment.

    We value the different backgrounds, experiences and outlooks which exist on our team, believing it will achieve the best results — especially with strong teamwork and collaboration. We believe the simplest way to do something is always the best first option. Our start-up culture embraces new ideas, and we don't worry about moving on when an idea does not pan out.

Our Work & Approach

Science Corporation is a leader in the field of brain-computer interface (BCI) technology, and the emerging field of neural engineering more broadly. We are driven by the conviction that everyone deserves control over their lives, and we prioritize patient rights, especially the right to privacy, in all we do.

Vertical Integration

We have significant in-house capabilities ranging from fabricating transistors to high-throughput cell editing to complex animal behavior, all integrated into one Science team. Our multidisciplinary approach enables us to push boundaries others have to simply accept.

Collaborate with Science

Commitment to Our Patients

We recognize our work is new and needs to be thoroughly explained and understood. We believe that neurotechnology is on the cusp of important breakthroughs that will significantly improve human life. We are determined to help lead that effort, and to make sure patients have the best and most complete access possible.

Science for Patients
A microfabrication engineer works with an intricate sputterer machine.

Recent News

Science Announces Positive Preliminary Results For Vision Restoration In Pivotal Clinical Trial

Science's "Brain Computer Toolkit"

– Bloomberg

Science Corp Announces New Suite of Neural Engineering Products to Accelerate Innovation and Reduce Complexity & Cost Industry Wide

SciFi: Ruggedized, WiFi-Enabled Synapse-Compatible Headstage

Synapse: Flexible, Powerful Standard API for Neural Interface Devices

Prioritizing the Science Eye and PRIMA

Science Corporation Welcomes Tricia Gugler as Chief Financial Officer, Alex Feerst as Chief Legal Officer, and Joe Mornin as General Counsel

Brain-Computer Interfaces and Patients' Rights: Some Key Principles

Durham County Commissioners Unanimously Approve Incentives for Science Foundry Expansion

Nixels and Pixels: Introducing Science's Chip Families for Neural Recording And Stimulation

"Bionic Eye Gets a New Lease of Life"

– IEEE Spectrum

Welcoming Pixium Vision’s PRIMA retinal prosthesis to Science

"Restoring sight is possible now with optogenetics"

– The Washington Post

Launching Science Foundry

Read the Science Lightsheet research paper preprint on bioRxiv

Science Acquires North Carolina Fab and Other MEMSCAP Assets

Announcing the Science Eye

Open Positions